Nanexa - Exciting Year Ahead
2021-03-03 08:30:00
Redeye raises its base case following solid progress in Nanexa's pipeline and a clearer view of the financial situation following the outcome of the warrant program and first investment from Applied Ventures. In our view, 2021 will be a pivotal year for Nanexa - with the readout from the phase I study of NEX-18 as the most important trigger.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/